No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
50 (estimated)
Sponsor
Flint Rehabilitation Devices, LLC · Industry
Who this trial is looking for
This trial is looking for people who have had a stroke less than 30 days ago. Participants will use the MiGo Tracker to monitor their home exercise program while receiving regular care for their recovery.
Are You a Good Fit for This Trial?
You may be able to join if
I have had one or more strokes less than 30 days ago.
I have an Upper Extremity Fugl-Meyer Score between 6 and 55.
I do not have moderate to severe pain.
You may not be able to join if
I am under 18 years old.
I cannot follow 2-step commands.
I have another neurological condition like Parkinson's Disease.
I have other serious medical conditions that could affect my participation.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
This project will determine the safety and effectiveness of a MiGo Tracker RTM program in a randomized controlled trial with individuals with subacute stroke (N=50). Participants will be randomly assigned to either the MiGo Tracker RTM program (intervention group) or prescription of home exercises with no monitoring (usual care/control group). All participants will still receive usual post-stroke …
This project will determine the safety and effectiveness of a MiGo Tracker RTM program in a randomized controlled trial with individuals with subacute stroke (N=50). Participants will be randomly assigned to either the MiGo Tracker RTM program (intervention group) or prescription of home exercises with no monitoring (usual care/control group). All participants will still receive usual post-stroke care, including outpatient rehabilitation. The main question this study aims to answer is: Does a MiGo Tracker RTM program lead to significantly greater motor recovery at three-months post stroke than the usual care group. If successful, MiGo Tracker will lead to increased home exercise adherence and improved health outcomes for thousands of individuals following stroke.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Experienced one or more strokes less than one month (30 days) prior
* Upper Extremity Fugl-Meyer Score \> 5 and \<= 55 out of 66
* Absence of moderate to severe pain (\<= 4 on the 10 point visual-analog pain scale)
Exclusion Criteria:
* age \<18 years old
* Unable to follow …
Inclusion Criteria:
* Experienced one or more strokes less than one month (30 days) prior
* Upper Extremity Fugl-Meyer Score \> 5 and \<= 55 out of 66
* Absence of moderate to severe pain (\<= 4 on the 10 point visual-analog pain scale)
Exclusion Criteria:
* age \<18 years old
* Unable to follow 2-step commands
* Other neurological diagnosis (e.g. Parkinson's Disease)
* Other severe concurrent medical conditions that may prevent the participants from completing the 3-month study
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.